Le Lézard
Classified in: Health
Subject: MRR

Top 10 Game-Changers in the Medical Plastics Industry

"Medical Plastics: Global Markets Set to Surge from $25.6 billion to $41.2 by 2028, Driven by Increasing Demand for Advanced Healthcare Solutions", According to Latest BCC Research Study

BOSTON, June 13, 2024 /PRNewswire/ -- In the ever-evolving landscape of healthcare, medical plastics play a pivotal role in innovation, efficiency, and safety. From advanced prosthetics to essential medical devices, these materials are the backbone of modern medicine. The medical plastics industry involves the production and use of plastic materials specifically designed for healthcare applications. These plastics are used to make a wide range of medical products and devices, from everyday items like syringes and tubing to advanced surgical instruments and implants. Medical Plastics: Global Markets is fueling this growth, with the market value expected to reach $41.2 billion by the end of 2028, growing at a compound annual growth rate (CAGR) of 10.0%.


Here's a rundown of the top 10 companies leading the charge in the global medical plastics market, transforming the way we approach healthcare.

  1. DuPont
    DuPont is a powerhouse in the world of medical plastics. Their materials, like Delrin and Zytel, are known for being strong, durable, and safe for medical use, making them perfect for things like medical devices and equipment.
  2. BASF
    BASF is a giant in the chemical industry, and their medical plastics are top-notch. Their products, such as Ultrason and Ultradur, are widely used because they can be sterilized easily and are very reliable.
  3. SABIC
    SABIC provides high-quality plastics that are essential in the medical field. Their Lexan and ULTEM materials are clear and tough, making them ideal for use in medical tubing and diagnostic equipment.
  4. Covestro
    Covestro specializes in high-tech plastics that are perfect for medical applications. Their Makrolon polycarbonate is popular for making surgical instruments and drug delivery devices because it is clear, strong, and easy to sterilize.
  5. Solvay
    Solvay offers a wide range of high-performance plastics for the medical industry. Their Ixef and Udel materials are known for their strength and heat resistance, making them suitable for reusable medical devices and sterilization trays.
  6. Eastman Chemical Company
    Eastman's medical-grade plastics are known for being reliable and consistent. Their Tritan copolyester is especially popular for making durable and chemical-resistant medical devices like fluid management systems and surgical instruments.
  7. Celanese Corporation
    Celanese is a leader in producing high-performance engineered materials. Their Hostaform and Vectra plastics are used in orthopaedic devices and inhalation systems because they are strong, low-friction, and wear-resistant.
  8. Ensinger
    Ensinger is a key player in the medical plastics market with their TECAPEEK and TECAFLON products. These materials are highly biocompatible and can withstand harsh sterilization processes, making them perfect for implants and surgical tools.
  9. Röchling Medical
    Röchling Medical makes precise medical components from advanced plastics. Their expertise ensures that their products meet high standards of safety and performance, making them a trusted supplier for medical device makers.
  10. Saint-Gobain
    Saint-Gobain offers a wide range of medical-grade plastics for fluid handling, filtration, and bioprocessing. Their Tygon tubing is well-known in the industry for its flexibility, clarity, and chemical resistance, making it ideal for various medical uses.

These companies are not just suppliers; they are innovators, pushing the boundaries of what's possible in medical technology. Thanks to their cutting-edge materials, healthcare is becoming safer, more effective, and more accessible for people around the world.

Click here to download a sample report on "Medical Plastics: Global Markets."

For further information or to make a purchase, please get in touch with [email protected].

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: [email protected],
Phone: +1 781-489-7301

For media inquiries, email [email protected] or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg



These press releases may also interest you

at 05:30
Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced positive results of its first-in-human...

at 05:30
The global esophageal cancer market stood at US$ 2.2 billion in 2023, and the global market is projected to reach US$ 4.6 billion in 2034. The esophageal cancer market is anticipated to expand at a CAGR of 6.7% between 2024 and 2034. The esophageal...

at 05:17
Second Quarter 2024 Total revenue increased 12 per cent, 11 per cent at constant exchange rates, (CER), to SEK 5,442 M (4,872)Haematology revenue increased 13 per cent at CER to SEK 3,866 M (3,430), reflecting growth in all medicines, mainly driven...

at 05:05
CatalYm today announced the completion of a $150 million Series D financing. The oversubscribed round was led by new investors, Canaan Partners and Bioqube Ventures, and joined by Forbion's Growth Opportunities Fund ("Forbion Growth"), Omega Funds...

at 05:00
Owing to different key contributing factors, the electroencephalography device market is expected to advance through the forecasted era at a promising CAGR...

at 04:23
Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has approved the...

News published on and distributed by: